Search research articles
Contact Us
Filters
Showing results (1-10 of 115) with videos related to
Page
of 12
Sort By:
Current Opinion in Pulmonary Medicine
|
June 2, 2005
The utility of fluorescence in-situ hybridization in the diagnosis of malignant pleural effusion
Michael Fiegl
Leukemia Research
|
December 18, 2010
Hypoxia and expression of hypoxia-related proteins in acute myeloid leukemia
Michael Fiegl, Karsten Spiekermann
The New England Journal of Medicine
|
December 3, 2004
Circulating epithelial cells in breast cancer
Michael Fiegl, Hubert Denz
The New England Journal of Medicine
|
June 28, 2002
Monoclonal gammopathy of undetermined significance
Michael Fiegl, Richard Greil
Experimental Hematology
|
April 28, 2016
Microenvironmental oxygen partial pressure in acute myeloid leukemia: Is there really a role for hypoxia?
Christina T Rieger, Michael Fiegl
Medizinische Klinik (Munich, Germany : 1983)
|
April 12, 2007
[Current therapeutic strategies in the management of acute myeloid leukemia]
Michael Fiegl, Wolfgang Hiddemann, Jan Braess
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
March 24, 2012
Prognostic and predictive value of cell cycle deregulation in non-small-cell lung cancer
William Sterlacci, Michael Fiegl, Alexandar Tzankov
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 13, 2003
Correspondence re: T. Fehm et al., Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin. Cancer Res., 8: 2073-2084, 2002
Michael Fiegl, Brigitte Kircher, Niklas Zojer
Cancer Research
|
March 5, 2009
Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism
Ismael Samudio, Michael Fiegl, Michael Andreeff
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
May 7, 2019
Cluster Analysis According to Immunohistochemistry is a Robust Tool for Non-Small Cell Lung Cancer and Reveals a Distinct, Immune Signature-defined Subgroup
William Sterlacci, Michael Fiegl, Darius Juskevicius, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 115) with videos related to
Sort By:
Page
of 12
Current Opinion in Pulmonary Medicine
|
June 2, 2005
The utility of fluorescence in-situ hybridization in the diagnosis of malignant pleural effusion
Michael Fiegl
Leukemia Research
|
December 18, 2010
Hypoxia and expression of hypoxia-related proteins in acute myeloid leukemia
Michael Fiegl, Karsten Spiekermann
The New England Journal of Medicine
|
December 3, 2004
Circulating epithelial cells in breast cancer
Michael Fiegl, Hubert Denz
The New England Journal of Medicine
|
June 28, 2002
Monoclonal gammopathy of undetermined significance
Michael Fiegl, Richard Greil
Experimental Hematology
|
April 28, 2016
Microenvironmental oxygen partial pressure in acute myeloid leukemia: Is there really a role for hypoxia?
Christina T Rieger, Michael Fiegl
Medizinische Klinik (Munich, Germany : 1983)
|
April 12, 2007
[Current therapeutic strategies in the management of acute myeloid leukemia]
Michael Fiegl, Wolfgang Hiddemann, Jan Braess
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
March 24, 2012
Prognostic and predictive value of cell cycle deregulation in non-small-cell lung cancer
William Sterlacci, Michael Fiegl, Alexandar Tzankov
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 13, 2003
Correspondence re: T. Fehm et al., Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin. Cancer Res., 8: 2073-2084, 2002
Michael Fiegl, Brigitte Kircher, Niklas Zojer
Cancer Research
|
March 5, 2009
Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism
Ismael Samudio, Michael Fiegl, Michael Andreeff
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
May 7, 2019
Cluster Analysis According to Immunohistochemistry is a Robust Tool for Non-Small Cell Lung Cancer and Reveals a Distinct, Immune Signature-defined Subgroup
William Sterlacci, Michael Fiegl, Darius Juskevicius, et al.
Page
of 12